Media
Company news
ChemDiv Expands Modeling & Simulation Services Platform, Signs Tenth Collaborator in 2026 - Mondego Bio
ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), f...
Pop-Science
RNA Inhibitors: Small Molecules Targeting RNA | ChemDiv Libraries
Explore the new frontier of RNA Inhibitors and small molecules targeting RNA. Discover mechanisms, scientific validation, and purchase specialized screening libraries at ChemDiv.
Science & Nature Digest
Science & Nature Reviews, February 2022. Part II
Neurophysiology
Kelava, I., Chiaradia, I., Pellegrini, L. et al. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112–116 (2022)
Sex-based brain dif...
Pharma News
VY1706 Alzheimer's Gene Therapy Achieves 75% Tau Reduction in GLP Studies
oyager Therapeutics reports preclinical data showing its VY1706 gene therapy reduces tau protein by 75% in Alzheimer's-relevant brain regions over 6 months.